Overview

• Dr. Michael R. Scoma diagnosed Glanville’s years-long facial ordeal as a deep-tissue staph and fungal infection after reviewing her history of inconclusive tests.
• The first phase of her multi-phase plan involves IV antibiotic therapy with antifungal medication administered through a PICC line.
• Scoma anticipates visible improvement within weeks and intends to transition her to long-term oral antibiotic maintenance under close monitoring.
• Glanville has accrued over $130,000 in medical bills and has partnered with healthcare strategist Rachel Strauss to negotiate and potentially recoup costs.
• She credits her social media outreach for connecting her to Scoma following 21 doctor consultations and multiple biopsies that failed to resolve her condition.